Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

The detoxification enzyme systems.

Liska DJ.

Altern Med Rev. 1998 Jun;3(3):187-98. Review.

2.

[Biologically active substances from medicinal plants as a factor of the organism detoxication].

Dadali VA, Makarov VG.

Vopr Pitan. 2003;72(5):49-55. Review. Russian.

PMID:
14619618
4.

Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.

Moon YJ, Wang X, Morris ME.

Toxicol In Vitro. 2006 Mar;20(2):187-210. Epub 2005 Nov 11. Review.

PMID:
16289744
6.

Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease.

Williams AC, Steventon GB, Sturman S, Waring RH.

J Inherit Metab Dis. 1991;14(4):431-5. Review.

PMID:
1749211
7.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
8.

Genetic contribution to variable human CYP3A-mediated metabolism.

Lamba JK, Lin YS, Schuetz EG, Thummel KE.

Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. Review.

PMID:
12406645
9.

Detoxification pathways in the liver.

Grant DM.

J Inherit Metab Dis. 1991;14(4):421-30. Review.

PMID:
1749210
10.

The pitfall of detoxifying enzymes.

Cantelli-Forti G, Hrelia P, Paolini M.

Mutat Res. 1998 Jun 18;402(1-2):179-83. Review.

PMID:
9675274
11.

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Verbeeck RK.

Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2. Review.

PMID:
18762933
12.

Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.

Rushmore TH, Kong AN.

Curr Drug Metab. 2002 Oct;3(5):481-90. Review.

PMID:
12369894
13.

[A prognostic factor for the risk of developing pathological processes based on the polymorphism of the enzymes of xenobiotic metabolism].

Piruzian LA, Sukhanov VA, Saprin AN.

Fiziol Cheloveka. 2000 Mar-Apr;26(2):115-23. Review. Russian. No abstract available.

PMID:
10816948
14.

Neonatal hepatic drug elimination.

Gow PJ, Ghabrial H, Smallwood RA, Morgan DJ, Ching MS.

Pharmacol Toxicol. 2001 Jan;88(1):3-15. Review.

PMID:
11169155
15.

Environmental and chemical carcinogenesis.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.

PMID:
15489140
16.
17.

Induction of phase I, II and III drug metabolism/transport by xenobiotics.

Xu C, Li CY, Kong AN.

Arch Pharm Res. 2005 Mar;28(3):249-68. Review.

PMID:
15832810
18.

Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer.

Williams JA, Phillips DH.

Cancer Res. 2000 Sep 1;60(17):4667-77. Review.

19.

Cytochromes P450 and metabolism of xenobiotics.

Anzenbacher P, Anzenbacherová E.

Cell Mol Life Sci. 2001 May;58(5-6):737-47. Review.

PMID:
11437235
20.

The drug-metabolizing enzymatic system and the experimental tools used for in vitro toxicology for metabolic studies.

Testai E.

Cell Biol Toxicol. 2001;17(4-5):271-85. Review. No abstract available.

PMID:
11768594

Supplemental Content

Support Center